The pharmaceutical research and services company is based in WuXi city, Jiangsu province. Photo: Handout
WuXi Biologics halts trading after US Commerce Department list sparks record 32 per cent slump
- WuXi Biologics says ‘unverified list’ will have no impact on its business or services and plans to take measures to remove its subsidiaries from the list
- The US Commerce Department announced restrictions on transactions with 33 Chinese entities, placing them on the unverified list
The pharmaceutical research and services company is based in WuXi city, Jiangsu province. Photo: Handout
Corrected [3:57pm, 8 Feb, 2022]
- [3:57pm, 8 Feb, 2022]
Corrects changes in the market value of stocks in the second and third paragraph
We are part of the Trust Project What is it?
